Copy Link Print Information

Elexacaftor

(Synonyms: VX-445)
51 Cited Publications
Revisión del cliente

Based on 51 publication(s) in Google Scholar

Elexacaftor (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). Elexacaftor (VX-445, Compound 1) facilitates the processing and trafficking of CFTR to increase the amount of CFTR at the cell surface.

Para uso exclusivo en investigación. No vendemos a pacientes.

  • Pureza: 99.26%
  • No. CAS: 2216712-66-0
  • Fòrmula: C26H34F3N7O4S
  • Peso molecular:597.65
  • Almacenamiento:
    Powder   -20°C, 3 years , 4°C, 2 years ; In solvent   -80°C, 2 years , -20°C, 1 year
  • Elexacaftor Chemical Structure
    Elexacaftor Chemical Structure
  • Experimental Validation Results for Elexacaftor
  • Experimental Validation Results for Elexacaftor
  • Experimental Validation Results for Elexacaftor
  • Experimental Validation Results for Elexacaftor
  • Experimental Validation Results for Elexacaftor
  • Experimental Validation Results for Elexacaftor
No. CAS: 2216712-66-0
Tamaño
Precio
Stock
Cantidad
Amount: USD 0.00
Please select quantity
or
or

* Seleccione Cantidad antes de agregar artículos.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Other Forms of Elexacaftor:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Encuentre su distribuidor local Your local distributor: Hycultec GmbHHycultec
  • Actividad biológica
  • Chemical Information
  • Solvente y solubilidad
  • Pureza y Documentación
  • Referencias
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

Publications Citing Use of MedChemExpress (MCE) Elexacaftor

More
Customer Validation & Images
WBBio/Physico-chemical AssayOthers
  • Others
  • Bio/Physico-chemical Assay
  • Bio/Physico-chemical Assay
  • WB
  • WB
  • Others
Keywords
MOQ
Minimum order quantity
100 mg

Obtener un presupuesto En stock

Other size
Obtener un presupuesto
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Inicie sesiòn
Registrar
Sign in to MedChemExpress
Registrar una cuenta nueva

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • Elexacaftor Chemical Structure
    Elexacaftor Chemical Structure
    1/16
  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: JCI Insight. 2026 Mar 23;11(6):e198846. [Abstract]

    Customer Validation
     Representative immunogold electron microscopy images showing the distribution of overexpressed F508del-CFTR-GFP in HEK293T cells. Cells were treated for 24 hours with DMSO (Veh), ETI (3 μM VX-445, 10 μM VX-661, and 1 μM VX-770) plus control peptide (ETI + 25 μM CP), or ETI plus PI3Kγ MP (ETI + 25 μM PI3Kγ MP). HEK293T cells expressing WT CFTR-GFP served as positive controls.

  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Jul 2;134(16):e176328. [Abstract]

    Customer Validation
     Subsequent to amiloride, short-circuit current (Isc) was increased by the C2 CFTR correctors VX-445 (10 μM).

  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2024 Jul 2;134(16):e176328. [Abstract]

    Customer Validation
     Recording of force in millinewtons (mN) over time from a single mesenteric artery showing preconstriction with the prostaglandin mimetic U46619 (1 × 10−7 to 5 × 10−7 M), after which the ability of increasing concentrations of VX-445 (Elexacaftor) to induce vasorelaxation was assessed. We added 0 Ca2+ at the end to determine maximal vasorelaxation.

  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Cyst Fibros. 2023 May;22(3):525-537. [Abstract]

    Customer Validation
     Elexacaftor/Tezacaftor (elexa/teza; 3 μM/10 μM; 24 h) combination causes a significant increase in the expression of the mature protein, with no changes in the expression of the immature, core-glycosylated form (B band) in Epithelia.

  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: Am J Respir Crit Care Med. 2021 Nov 15;204(10):1231-1235. [Abstract]

    Customer Validation
     Western blot of CFTR variances transiently expressed in HEK293 (left) or CFBE (right) cells. Cells were transfected with indicated CFTR variances overnight and then treated with VX445 (Elexacaftor: 2 μM) /VX661 or DMSO for 24 hours.

  • 1/16

    Elexacaftor purchased from MedChemExpress. Usage Cited in: J Clin Invest. 2021 Aug 16;131(16):e150398. [Abstract]

    Customer Validation
     Human airway epithelia from CFTR-ΔF508 donors were treated for 48 hours with a combination of elexacaftor (3 μM), tezacaftor (18 μM), and ivacaftor (1 μM), either alone or in the presence of TNF-α+IL-17. pHASL was measured using SNARF-1-dextran.

  • Elexacaftor